The intralesional interleukin-2 is an adequate palliative treatment in cutaneous metastases of melanoma

G Ital Dermatol Venereol. 2017 Aug;152(4):400-401. doi: 10.23736/S0392-0488.16.05342-6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage
  • Female
  • Humans
  • Interleukin-2 / administration & dosage*
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Palliative Care / methods
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Interleukin-2